the promise of bispecific antibodies in the treatment of nhl
Published 1 year ago • 128 plays • Length 1:17Download video MP4
Download video MP3
Similar videos
-
4:27
the possibility of combining car-t therapy and bispecific antibodies in the treatment of nhl
-
2:05
clinical guidance for the use of bispecific antibodies in nhl
-
1:34
how will bispecifics impact the treatment of nhl?
-
2:33
the role of bispecific antibodies in the treatment of patients with multiple myeloma
-
1:56
the future of bispecific antibodies in the treatment and management of r/r follicular lymphoma
-
38:40
bispecific antibodies in lymphoma: an update
-
43:38
webinar - bispecific antibodies: the next generation of antibody therapeutics
-
9:41
subcutaneous epcoritamab in r/r b-cell non-hodgkin lymphoma
-
1:15
the role of bispecific antibodies in the treatment of r/r large b-cell lymphoma
-
1:30
bispecific antibodies for r/r aggressive b-cell lymphomas
-
2:25
advancements and challenges in bispecific antibodies for the treatment of b-nhl
-
2:39
advancements in bispecific and trispecific antibodies for the treatment of lymphoma
-
1:54
the important role of bispecific antibodies in the future treatment of r/r dlbcl
-
2:39
the role of bispecific antibodies in the treatment landscape for r/r dlbcl
-
2:43
bispecific antibodies for non-hodgkin lymphoma
-
6:23
the benefits of bispecific antibodies over car-t cell therapy in lymphoma
-
1:03
using bispecific antibodies instead of chemotherapy to reach pre-transplant remission in b-all
-
1:45
the advent of bispecific antibodies for multiple myeloma
-
10:25
key highlights in nhl: updates in mcl, the role of transplantation, and novel bispecific antibodies
-
2:00
the success story of bispecific and trispecific antibodies
-
0:58
first-in-human trial of cln-978, a novel cd19 bispecific antibody, for the treatment of r/r b-nhl
-
3:12
the role of bispecific antibodies in r/r nhl: the biology of these agents and what the future holds